The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Open accessAbstract
To assess the clinical significance of lupus anticoagulants (LAs) and antiphospholipid antibodies (aPLs) toward thrombosis and abortions, we measured them in 112 patients whose samples were available at enrollment in the warfarin in the antiphospholipid syndrome (WAPS) study. Enzyme-linked immunosorbent assay (ELISA) and coagulation test values in the highest and lowest tertiles were compared. When considered separately, IgG antibodies to β2-glycoprotein I (aβ2GPI) and prothrombin (aPT) were associated with anamnestic arterial and venous thrombosis, respectively, and those to annexin AV (aAnAV) with abortions. IgM antibodies to protein S and the lupus ratio of the dilute prothrombin time were associated with prospective thrombosis. No other association for IgM antibodies was seen. LA-positive patients who carried aβ2GPI antibodies were at risk of anamnestic arterial and total thrombosis and aPT antibodies to that of anamnestic venous and total thrombosis. LA-positive patients who carried IgG aβ2GPI and aAnAV antibodies were at risk for both anamnestic abortion and prospective thrombosis. Overall, these data support the inclusion of aβ2GPI antibodies in and suggest the removal of anticardiolipin antibodies from the laboratory criteria of the antiphospholipid syndrome. They also suggest that the measurement of aPT and aAnAV antibodies is useful in some selected situations and that there is little role for IgM antibody detection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, a considerable proportion of patients with LA will not develop thrombosis despite the presence of aPL-associated autoantibodies at high titers [7].”
From Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While triple positivity has been shown to be a significant thrombotic risk factor in the WAPS study [7], several more recent prospective cohorts have also observed a lack of association between triple positivity or other LA-related autoantibodies and thrombosis [30, 32, 33].”
From Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant (2017) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266
Self-citationBrandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Kearon, C., Gent, M., Hirsh, J., Weitz, J. I., Kovacs, M. J., Anderson, D. R., Turpie, A. G. G., Green, D., Ginsberg, J. S., Wells, P. S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,057
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972 · cited 2×
“In 2003, two systematic reviews of the literature on LA, aCL, aβ2GPI and aPT antibodies showed that LA are the strongest risk factors for both arterial and venous thrombosis, whereas such a role did not clearly emerge for the other antibodies, unless in some selected clinical scenarios (10, 11).”
BackgroundResultSelf-citationCrowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed Central · Cited by 724
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 718
Research works printed but not linked: 2
- Harris, 1987, Evaluation of the anticardiolipin antbody test: report of a standardization workshop, held April 4th, 1986., Clin Exp Immunol, 68, 215
- Van Heerde, 2004, Localization of annexin A5 in human tissues., Annexins, 1, 56
Cited by
Sorted by citations
Items 101–170 of 170
Clinical significance of anti-annexin V antibody in acute cerebral ischemia
Lee, K. O., Kim, W. J., Na, S.-J., Heo, J. H., & Lee, K.-Y. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.017 · Cited by 12
Immunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome
Martirosyan, A., Petřek, M., Kishore, A., & Manukyan, G. P. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3441 · Cited by 12
Current management of antiphospholipid syndrome-related thrombosis
Puente, D., Pombo, G., & Forastiero, R. R. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.112 · Cited by 11
Olah, Z., Szarvas, M., Bereczky, Z., Kerenyi, A., Kappelmayer, J., & Boda, Z. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0236-oa · Cited by 11
IgM anti-protein S antibodies as a risk factor for venous thrombosis
Borrell, M., Tirado, I., Mateo, J., Oliver, A., Santamaría, A., & Fontcuberta, J. (2008) · Haematologica · doi:10.3324/haematol.12575 · Cited by 10
Giles, I., & Rahman, A. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.01.009 · Cited by 11
Anticoagulating patients with high-risk acquired thrombophilias
Skeith, L. (2018) · Hematology · doi:10.1182/asheducation-2018.1.439 · Cited by 10
Risk factors and recurrent thrombosis in primary antiphospholipid syndrome
Cheldieva, F. A., Shumilova, A. A., Cherkasova, M. V., Glukhova, S. I., Lila, A. M., Nasonov, E. L., & Reshetnyak, T. M. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00114 · Cited by 9
Kim, H., Kim, J.-E., Hwang, S. M., Lee, H. R., Han, K. S., & Kim, H. K. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613497424 · Cited by 8
Antiphospholipid syndrome: A diagnostic challenge
Mallhi, R. S., Kushwaha, N., Chatterjee, T., & Philip, J. (2016) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2016.05.001 · Cited by 8
Pelusa, H. F., Pezzarini, E., Basiglio, C. L., Musuruana, J. L., Bearzotti, M., Svetaz, M. J., Daniele, S. M., Bottai, H., & Arriaga, S. M. M. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216672248 · Cited by 8
Devreese, K. M. J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3175-1_20 · Cited by 8
Novel Drugs in Myeloma: Harnessing Tumour Biology to Treat Myeloma
Boyd, K. D., Davies, F. E., & Morgan, G. J. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-85772-3_8 · Cited by 7
Management of the antiphospholipid syndrome
Espinosa, G., & Cervera, R. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0004-6 · Cited by 7
Anti-prothrombin antibodies are associated with thrombosis in children
Rask, O., Hillarp, A., Berntorp, E. E., & Ljung, R. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.02.007 · Cited by 7
Antibodies directed against annexin A2 and obstetric morbidity
Salle, V., Schmidt, J., Смаил, А., Mazière, C., Conte, M. A., Brulé, A., Mazière, J., Cadet, E., Herpe, Y.-É., & Duhaut, P. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.08.010 · Cited by 7
Carubbi, F., Alunno, A., Cipriani, P., Bistoni, O., Scipioni, R., Liakouli, V., Ruscitti, P., Berardicurti, O., Bartolomeo, S. D., Gerli, R., et al. (2018) · Current Rheumatology Reviews · doi:10.2174/1573397114666180320113603 · Cited by 7
Treatment of Antiphospholipid Syndrome
Espinosa, G., & Cervera, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10055-5 · Cited by 7
Giles, I., Lambrianides, A., & Rahman, A. (2008) · Lupus · doi:10.1177/0961203308091541 · Cited by 7
Breen, K. A. (2017) · Wiley eBooks · doi:10.1002/9781119095606.ch8 · Cited by 7
Sénant, M., Rostane, H., Fernani-Oukil, F., Hosking, F., Bellery, F., Courchinoux, A., Tartour, É., Darnige, L., & Dragon‐Durey, M. (2015) · Journal of Immunology Research · doi:10.1155/2015/983094 · Cited by 6
Analytical dilemmas in lupus anticoagulant detection
Moore, G. W. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00104 · Cited by 5
Song, S., Rajah, G. B., Ding, Y., Ji, X., & Meng, R. (2021) · BMC Neurology · doi:10.1186/s12883-020-02035-1 · Cited by 5
Clinical immunology Bouquet variety of antiphospholipid antibodies in recurrent pregnancy loss
Baleva, M. P., Karagyozova, Z. P., Nikolova-Vlahova, M. K., Nikolov, K. V., & Nikolov, P. K. (2014) · Central European Journal of Immunology · doi:10.5114/ceji.2014.45947 · Cited by 4
Antiphospholipid syndrome: new light comes from in vivo studies
Forastiero, R. R. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02686.x · Cited by 4
Devreese, K. M. J. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.01.002 · Cited by 4
Köse, R., Vega, J., Burgos, C., & Erkan, D. (2025) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2025.152768 · Cited by 3
RESULTADOS OBSTÉTRICOS EN GESTANTES DIAGNOSTICADAS DE SÍNDROME ANTIFOSFOLÍPIDO
Félix, C., Badillo, M. P. C., Añón, I., Malde, F. J., Cáliz, R., & Puertas, A. (2021) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.05.005 · Cited by 3
Clinical Management of Antiphospholipid Syndrome-Related Thrombosis
Espinosa, G., & Cervera, R. (2010) · The Open Autoimmunity Journal · Cited by 3
Rand, J. H., & Wolgast, L. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00020-8 · Cited by 3
Tselios, K., & Urowitz, M. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00010-7 · Cited by 3
Jiang, H., Yang, Y., Tang, Z., Pan, H., Liu, H., Cheng, X., Su, Y., Ye, J., Hu, Q., Meng, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-04097-y · Cited by 2
Antiphospholipid Syndrome—Diagnostic and Methodologic Approach
Stańczewska, A., Szewczyk‐Golec, K., & Hołyńska-Iwan, I. (2025) · Metabolites · doi:10.3390/metabo15080500 · Cited by 2
Pelusa, H. F., Valdés, Á., Bearzotti, M., Svetaz, M. J., Daniele, S. M., Sjoberg, I., Fornasiero, L., Bottai, H., Almará, A. M., Ghersevich, S. A., et al. (2012) · Cited by 2
Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies
Pierangeli, S. S., & Rand, J. H. (2009) · Technical report · doi:10.1016/s1571-5078(08)00403-0 · Cited by 2
Antiphospholipid antibody syndrome—an overview
Sridevi, C., & Raju, P. K. (2011) · Journal of Indian College of Cardiology · doi:10.1016/s1561-8811(11)80022-2 · Cited by 2
Diagnosis of antiphospholipid syndrome
Bertolaccini, M. L., & Khamashta, M. A. (2008) · Expert Review of Hematology · doi:10.1586/17474086.1.2.183 · Cited by 2
Antigen Specificity of Antiphospholipid Syndrome-Related Antiphospholipid Antibodies
Forastiero, R. R. (2010) · The Open Autoimmunity Journal · Cited by 2
Olschewski, H. (2008) · Der Pneumologe · doi:10.1007/s10405-007-0188-2 · Cited by 2
Síndrome antifosfolípido: Más allá de los criterios diagnósticos
Correa, D. G. G. (2022) · Revista Reumatología al Día. · doi:10.62484/rad.v16i2.4630 · Cited by 1
Laboratory Criteria of Antiphospholipid Syndrome Need to be Updated or Strictly Followed
Martinuzzo, M. E. (2010) · The Open Autoimmunity Journal · Cited by 1
Saleh, M. A.-D., Aboud, A. A., & Mohammed, M. A. (2017) · Diyala Journal for Pure Science · doi:10.24237/djps.1301.190c · Cited by 1
Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome
Ruiz‐Irastorza, G., Pengo, V., Tektonidou, M. G., Ruiz‐Arruza, I., Cuadrado, M. J., & Khamashta, M. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3194-7_11 · Cited by 1
Ocampo, C. R., Gutiérrez, L. A., Padilla, L. M. R., Navas, M. A. M., Franco, C. J. V., Gutiérrez-Marín, J. H., & Campo, M. N. C. (2020) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2020.01.002 · Cited by 2
Thrombolysis in antiphospholipid syndrome: Current hematologic perspectives
McNall‐Knapp, R. Y. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0011-z · Cited by 1
Antiphospholipid Antibodies and Syndrome
Cervera, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-948-7 · Cited by 3
HACHULLA, E. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71447-4.50012-x
Rocha, L. K. A., Galante, N. Z., Alvarez, V. A. C., Areco, K. C. N., Noguti, M. A. E., Amaral, R. Q., Andrade, L. E. C., Peres, C. A., Pestana, J. O. M., & Lourenço, D. M. (2009) · Brazilian Journal of Nephrology · doi:10.1590/s0101-28002009000400006
Zakrzepica żylna i tętnicza jako objaw zespołu antyfosfolipidowego
Lehmann-Kopydłowska, A., & Zawilska, K. (2013) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2013.07.262
New insights into the management of antiphospholipid syndrome-related thrombosis
Puente, D., & Forastiero, R. R. (2008) · Future Rheumatology · doi:10.2217/17460816.3.1.85
What have we Learned Regarding Pregnancy Morbidity and Antiphospholipid Syndrome
Grand, B. E., & Voto, L. S. (2010) · The Open Autoimmunity Journal
Clinical Studies Examining Thrombosis Related to Autoimmune Antiphospholipid Antibodies
Bertolaccini, M. L., & Khamashta, M. A. (2010) · The Open Autoimmunity Journal
Antiphospholipid syndrome in terms of cardiovascular surgery
Uyar, İ. S. (2015) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2015.10280
Diagnosing Antiphospholipid Antibody Syndrome
Green, D. (2007) · Journal watch · doi:10.1056/oh200709110000001
Tincani, A., Casu, C., Cartella, S., ZIGLIOLI, T., & Cattaneo, R. (2010)
The patient at risk from thrombosis and bleeding disorders
Greer, S. N. A. I. (2008) · CRC Press eBooks · doi:10.3109/9780203092200-14
Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome
Amengual, O., Bertolaccini, M. L., & Atsumi, T. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00004-1
Patnaik, M. M., Wudhikarn, K., Shroff, M. M., Killeen, A. A., Reding, M. T., & Kasthuri, R. S. (2008) · Blood · doi:10.1182/blood.v112.11.5343.5343
Ocampo, C. R., Gutiérrez, L. A., Padilla, L. M. R., Navas, M. A. M., Franco, C. J. V., Gutiérrez-Marín, J. H., & Campo, M. N. C. (2020) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2020.06.003
Treatment of Thrombosis in Antiphospholipid Syndrome
Braham, S., Bucciarelli, P., & Moia, M. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_15
Stankić, D., & Miljić, P. (2022) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk3-32463
The patient at risk from thrombosis and bleeding disorders
Nelson, S. M., & Greer, I. A. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092200.011
Mattar, M., Ahmed, H. M. A., & Ragab, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-25782-8_8
Ali, F., Zubair, A., Ahmed, A. A., Jalbani, A., & Mumtaz, H. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.109015
Not So BenignAntiphospholipid Antibody Syndrome: Clots, Complement, and Catastrophe!
Gerber, G. F., & Chaturvedi, S. (2024) · The Hematologist · doi:10.1182/hem.v21.1.2024112
Wan, J., Xu, S., Yang, J., Liu, Q., Yang, R., Kang, W., Yang, J., & Xing, X. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03815-6
Tripathi, A., Sharma, T., & Aronow, W. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-93459-9_31
Song, S.-Y., Rajah, G. B., Ding, Y.-C., Ji, X.-M., & Meng, R. (2021) · Figshare · doi:10.6084/m9.figshare.13543924
Metadata
- Authors
- Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T.
- Affiliations
- Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy;
- Mario Negri Sud Foundation (IT)
- Ulleval Hospital, Oslo, Norway;
- Stago (France) (FR)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-08-15
- Volume
- 110
- Issue
- 4
- Pages
- 1178-1183
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2084234423
- Cited by
- 170
- References
- 37
- Citations by year
- 2025: 5 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 8 · 2014: 14 · 2013: 7 · 2012: 8
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- antiphospholipid syndrome, antiphospholipid antibodies, lupus anticoagulant, anti-beta2-glycoprotein I antibodies, anticardiolipin antibodies, arterial thrombosis, venous thrombosis, miscarriage, thrombosis risk
- MeSH terms
- Abortion, Habitual, Adult, Aged, Aged, 80 and over, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Pregnancy, Pregnancy Complications, Hematologic, Prospective Studies, Risk Factors, Thromboembolism, Lupus Coagulation Inhibitor, Antiphospholipid Syndrome, Antibodies, Antiphospholipid, Antibodies, Anticardiolipin, beta 2-Glycoprotein I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
